Consistently, rescue assay applying si-RNA transfection and agonist indicated that the master metabolic pathway β-catenin/AMPK/SIRT1 was suppressed by TCPT treatment in SCLC. The gene discussed is SIRT1; the disease is small cell lung carcinoma.